Rakitina and co-authors reported that HSP90 inhibitors were effective in enhancing oxaliplatin-dependent caspase activation and cytotoxicity by down-regulating anti-apoptotic signaling and activating NF-κB in colon cancer cells [23]. This evidence concerns the gene NFKB1 and colonic neoplasm.